Search

Your search keyword '"Ferreiro-Iglesias, A"' showing total 479 results

Search Constraints

Start Over You searched for: Author "Ferreiro-Iglesias, A" Remove constraint Author: "Ferreiro-Iglesias, A"
479 results on '"Ferreiro-Iglesias, A"'

Search Results

1. Geographic variation of mutagenic exposures in kidney cancer genomes

2. Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions

3. Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU

4. A booster dose of SARS-COV-2 vaccine improves suboptimal seroconversion rates in patients with inflammatory bowel disease. Results of a prospective multicenter study of GETECCU (VACOVEII study)

5. Transcriptome- and proteome-wide association studies identify genes associated with renal cell carcinoma

6. Penile Cancers Attributed to Human Papillomavirus Are Associated with Improved Survival for Node-positive Patients. Findings from a Norwegian Cohort Study Spanning 50 Years

7. Impact of mesalazine on the response to COVID-19 vaccination in patients with inflammatory bowel disease: Results of a prospective multicentre study of GETECCU (VACOVEII study)

8. Impacto de la mesalazina en la respuesta a la vacunación contra la COVID-19 en pacientes con enfermedad inflamatoria intestinal. Resultados de un estudio prospectivo multicéntrico de GETECCU (VACOVEII)

9. Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU

10. The Mutographs biorepository: A unique genomic resource to study cancer around the world

11. Risk factors for melanoma by anatomical site: an evaluation of aetiological heterogeneity*

16. Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry.

18. Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNFα used for the treatment of IBD: Results from the VERNE study

19. Managing ulcerative colitis after surgery

20. WCN24-1870 CHRONIC RENAL LESIONS IN PATIENTS WITH RENAL CELL CARCINOMA ARE ASSOCIATED WITH ARISTOLOCHIC ACID EXPOSURE AND FASTER ACCUMULATION OF DNA DAMAGE

21. Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer

22. Implementation experience of a guideline on fall prevention in Centres Committed to Excellence in Care®

23. Prophylactic Versus Endoscopy-driven Treatment of Crohn’s Postoperative Recurrence: A Retrospective, Multicentric, European Study [PORCSE Study]

24. Safety and Effectiveness of Vedolizumab and Ustekinumab in Elderly Patients with Inflammatory Bowel Disease: A Real-Life Multicentric Cohort Study

26. P1170 Long-term outcomes of newly diagnosed Inflammatory Bowel Disease (IBD) patients: results from the nationwide EpidemIBD study of GETECCU

27. OP37 Effect of the HLA-DQA1*05 allele on the efficacy of ustekinumab in patients with Crohn's Disease. Multicenter study based on the ENEIDA registry of GETECCU

28. Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU

30. P021 Higher TNFα and IL-6 mucosal levels in ulcerative colitis patients with more severe endoscopic activity

33. P1115 Characteristics and management of pyoderma gangrenosum and erythema nodosum in patients with inflammatory bowel disease: PIONOSO multicenter study

34. P949 Effectiveness and safety of rectal tacrolimus in patients with ulcerative colitis. TACRO-TOPIC study. A multicenter study from the young group of GETECCU

35. P632 Isolation of a novel metalloproteinases transcriptional signature with robust anti-TNF therapy predictive power in patients with Ulcerative Colitis

36. P450 Influence of radon levels at home in the clinical course of inflammatory bowel disease incident patients

37. Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer

38. Preferences and satisfaction of IBD patients after switching from adalimumab 40 mg weekly to 80 mg every other week given as a single injection: the ADASCAL study

39. Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium

41. Real-world long-term effectiveness of ustekinumab in ulcerative colitis: results from a spanish open-label cohort.

42. Real-world long-term effectiveness of ustekinumab in ulcerative colitis: results from a spanish open-label cohort

43. Penile Cancers Attributed to Human Papillomavirus Are Associated with Improved Survival for Node-positive Patients. Findings from a Norwegian Cohort Study Spanning 50 Years

44. Is Occupation a Risk Factor for Developing Inflammatory Bowel Disease? A Case–Control Study

45. Genome-wide association meta-analysis identifies pleiotropic risk loci for aerodigestive squamous cell cancers.

47. Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) y de la Confederación de Asociaciones de Enfermedad de Crohn y Colitis Ulcerosa (ACCU) para el manejo de los aspectos psicológicos en la enfermedad inflamatoria intestinal

48. Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients

50. Fine mapping of MHC region in lung cancer highlights independent susceptibility loci by ethnicity

Catalog

Books, media, physical & digital resources